Login / Signup

Comparative effectiveness and safety of edoxaban, rivaroxaban, and apixaban in patients with venous thromboembolism: A cohort study.

Toshiki FukasawaTomotsugu SekiMasayuki NakashimaKoji Kawakami
Published in: Journal of thrombosis and haemostasis : JTH (2022)
In routine care, edoxaban, rivaroxaban, and apixaban appear to have similar effectiveness and safety in the treatment of VTE.
Keyphrases
  • venous thromboembolism
  • direct oral anticoagulants
  • healthcare
  • clinical practice
  • atrial fibrillation
  • combination therapy
  • affordable care act
  • health insurance